Table 3 Baseline symptom severity overall and by cannabis use status group.
From: Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment
Symptom | Overall | Non-use | Occasional use | Consistent use | p |
|---|---|---|---|---|---|
N = 216 | n = 146 | n = 28 | n = 42 | ||
M (SD) | M (SD) | M (SD) | M (SD) | ||
RSCL physical | 37.25 (10.06) | 35.88 (10.05) | 40.25 (10.60) | 39.98 (8.87) | 0.02 |
RSCL psychological distressB | 11.89 (3.95) | 11.36 (3.80) | 12.96 (4.05) | 13.02 (4.09) | 0.02 |
RSCL totalB | 49.14 (12.83) | 47.25 (12.77) | 53.21 (13.57) | 53.00 (11.24) | 0.01 |
ATSQB | 15.05 (6.78) | 14.08 (6.22) | 16.39 (6.05) | 17.52 (8.31) | 0.01 |
PROMIS* | |||||
Physical functionA | 43.76 (9.14) | 44.93 (9.27) | 39.45 (6.93) | 42.55 (9.11) | 0.01 |
Pain interference | 54.62 (10.49) | 53.27 (10.35) | 58.21 (10.26) | 56.94 (10.38) | 0.02 |
Sleep disturbance | 52.21 (8.95) | 51.41 (9.43) | 52.27 (7.18) | 54.93 (7.85) | 0.08 |
FatigueB | 52.83 (11.54) | 51.03 (11.20) | 55.06 (11.02) | 57.63 (11.65) | 0.002 |
Social functionA | 48.29 (10.42) | 49.91 (10.52) | 42.89 (7.97) | 46.26 (10.16) | 0.002 |
